Technology
Researchers identify potential new antiviral drug for COVID-19 – Medical Xpress
The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National Institutes…
The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National Institutes of Health. TEMPOL can limit SARS-CoV-2 infection by impairing the activity of a viral enzyme called RNA replicase. The work was led by researchers at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The study appears in Science.
“We urgently need additional effective, accessible treatments…
-
Noosa News21 hours agoDid you lose your ring?
-
Business24 hours agoWill GQG Partners shares rise from here? Macquarie reveals its forecast post-results
-
Noosa News20 hours agoThe only person detained at Brisbane’s Palestine rally
-
Business19 hours agoHow to turn $500 a month into $500,000 with ASX shares